4.0Sep 5, 2025Anonymous employeeCurrent employeeRecommendCEO approvalBusiness OutlookProsDisruptive technology and first to marketConsVery lean not much infrastructureShow more
4.0May 23, 2022Anonymous employeeCurrent employee, more than 5 yearsSeattle, WARecommendCEO approvalBusiness OutlookProsI can work on IT projects remotelyConsDon't know of any right nowShow moreHelpfulShare
4.0May 14, 2021Ceo-founderCurrent employeeSeattle, WARecommendCEO approvalBusiness OutlookProsVery dynamic, leading biotech R&D in otology space, expanding into other areas of neuro and infectious diseaseConsVery small. everyone reports to CEO of CMO is some wayShow moreHelpfulShare